Literature DB >> 15565790

School performance in adolescents with and without periventricular-intraventricular hemorrhage in the neonatal period.

Margot van de Bor1, Lya den Ouden.   

Abstract

Long-term sequelae of preterm birth have been studied extensively up until the age of 5 to 8 years. However, the cognitive development of adolescents born preterm has received limited attention. The objective of this study is to determine school performance in adolescents born very preterm. We have followed up a cohort of 484 infants born before 32 weeks of gestation in whom cranial ultrasound was routinely and systematically performed. School performance was assessed in the surviving adolescents at 14 years of age. The outcome variable divided the adolescents into three groups: (1) normal, (2) slow learners, and (3) special education. School performance data were obtained from 278 of 304 surviving adolescents; 129 performed normally, while 107 were slow learners, and 42 needed special education. From the unadjusted odds ratios for the need of special education by the various perinatal factors, only the odds ratio for periventricular-intraventricular hemorrhage was significantly associated (2.56, 95% confidence interval 1.17-4.86). Logistic regression analysis revealed that, after correction for possible confounding factors, the odds ratios for special education were significantly higher for adolescents with all grades of periventricular-intraventricular hemorrhage. Less than 50% of adolescents born before 32 weeks gestation perform normally in school. Periventricular-intraventricular hemorrhage, including the lower grades,does have an unfavorable additional effect on school performance.

Entities:  

Mesh:

Year:  2004        PMID: 15565790     DOI: 10.1053/j.semperi.2004.08.007

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  7 in total

1.  Elevated cerebral pressure passivity is associated with prematurity-related intracranial hemorrhage.

Authors:  Heather O'Leary; Matthew C Gregas; Catherine Limperopoulos; Irina Zaretskaya; Haim Bassan; Janet S Soul; Donald N Di Salvo; Adré J du Plessis
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

2.  General evaluation of periventricular-intraventricular hemorrhage in premature infants in mainland China.

Authors:  Jing Liu; Li-Wen Chang; Qi Wang; Gui-Lian Qin
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-06-01

3.  Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial.

Authors:  Judith S Mercer; Betty R Vohr; Margaret M McGrath; James F Padbury; Michael Wallach; William Oh
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

4.  The role of antenatal corticosteroids for improving the maturation of choroid plexus capillaries in fetal mice.

Authors:  Jing Liu; Zhi-Chun Feng; Xiao-Juan Yin; Hui Chen; Jing Lu; Xin Qiao
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

5.  Disrupted cerebellar development in preterm infants is associated with impaired neurodevelopmental outcome.

Authors:  Agnes Messerschmidt; Renate Fuiko; Daniela Prayer; Peter C Brugger; Eugen Boltshauser; Gerlinde Zoder; Walter Sterniste; Michael Weber; Robert Birnbacher
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

6.  Post hemorrhagic hydrocephalus and neurodevelopmental outcomes in a context of neonatal intraventricular hemorrhage: an institutional experience in 122 preterm children.

Authors:  Vianney Gilard; Alexandra Chadie; François-Xavier Ferracci; Marie Brasseur-Daudruy; François Proust; Stéphane Marret; Sophie Curey
Journal:  BMC Pediatr       Date:  2018-08-31       Impact factor: 2.125

Review 7.  Intraventricular haemorrhage and posthaemorrhagic ventricular dilatation: moving beyond CSF diversion.

Authors:  Aswin Chari; Conor Mallucci; Andrew Whitelaw; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2021-05-15       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.